Home Health and Wealth The Irreplaceable Pharmacist

The Irreplaceable Pharmacist

0
31
HubCare’s Vision is to Democratise Healthcare for Africans- Kareem
Pharm. Sesan Kareem

A few months ago, I watched a patient in our Lagos centre spend 40 minutes explaining her sickle cell history to a new clinician. Dates, crises, medications, complications — the kind of history that never quite fits the form, and always gets partially lost. Afterwards, she told me, almost apologetically, “I’m used to starting over.”

That moment has stayed with me, because it is not primarily a technology problem. It is a leadership problem. And it is one that AI is beginning to force us to confront.

We are in a strange period in health sector leadership. The tools have arrived faster than our thinking about them. Across Nigeria and the rest of Africa, health institutions are running on WhatsApp groups, handwritten drug registers, and muscle memory built over decades. Meanwhile, the same continent is absorbing AI health tools designed elsewhere, for patients elsewhere, in health systems structured nothing like ours. The question facing every health leader right now is not “should we adopt AI?” That debate is over. The question is who gets to shape how.

I run a speciality pharmacy and a coordinated care platform. We built Afiya, an AI health companion that currently supports over 15,000 users across 31 countries in more than 50 languages. I did not build it because AI is fashionable. I built it because our patients — people living with sickle cell disease, diabetes, hepatitis C, cancer — needed continuity of care between clinic visits that no human workforce could affordably provide at scale. Afiya doesn’t replace our pharmacists. It extends them. That distinction matters more than it sounds.

The loudest AI debate in healthcare right now centres on replacement: will AI replace doctors, pharmacists, nurses? I find this framing almost useless in the Nigerian context. We don’t have enough pharmacists, doctors and nurses. We don’t have enough diagnostics. We don’t have enough data infrastructure to power the AI systems being sold to us. Before we debate replacement, we need to talk about what we are building on.

This is where leadership comes in — and where most health sector leaders are falling short. Leadership in the age of AI is not about acquiring the technology. Any organisation with a credit card can do that. It is about three things that are considerably harder.

The first is knowing what problem you actually have. AI amplifies whatever capacity you point it at. If you point it at a broken referral pathway, you get a faster broken referral pathway. If you deploy a chatbot on top of a supply chain that cannot guarantee stock, you get patients who arrive having been told their medication is available, only to find it is not. I have seen this. Real leaders do the hard diagnostic work before the deployment decision.

The second is building institutional honesty. One of the more uncomfortable things AI does in health settings is generate data — about outcomes, about adherence, about where patients drop off, about which interventions actually work. In a culture where health administrators are accustomed to managing up with good news, this can feel threatening. But leadership means sitting with the numbers, even the unflattering ones, and building the capacity to act on them. At HubPharm, we track adherence rates, programme completion, and patient-reported outcomes not because funders ask for them, but because we cannot improve what we do not measure honestly.

The third — and most important — is deciding what AI must never be allowed to replace. This is the ethical core of AI leadership in healthcare, and it is underdiscussed. The patient who spent forty minutes re-telling her history needed someone to remember her, not just her records. She needed continuity of the relationship. There are moments in clinical care — breaking difficult news, navigating a patient’s refusal of treatment, supporting a family through a terminal diagnosis — that require a human being fully present. If AI leadership fails anywhere, it will fail here: in organisations where efficiency pressures quietly push human judgment out of the spaces it needs to stay.

The pharmacists and clinicians who will be most valuable in the next decade are not those who resist AI, but those who understand its limits at least as well as its capabilities. They will know when to trust the algorithm and when to override it. They will have cultivated the kind of trust with patients that no interface can replicate. They will read the room that the machine cannot read.

I went back to that patient a week later with her full history loaded into our care management system. She did not need to start over. She looked at me with an expression I have not forgotten.

That is what this is for. Not the efficiency. Not the investor deck. That moment.

Leadership in the age of AI means keeping that in view, especially when the technology makes it easy to forget.

 

Sesan Kareem is the founder and president of HubPharm Africa, a speciality pharmacy and coordinated care platform based in Lagos. He writes on health access, health systems, and the business of chronic care.

LEAVE A REPLY

Please enter your comment!
Please enter your name here